231 related articles for article (PubMed ID: 26932258)
21. Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial.
Hauser RA; Olanow CW; Kieburtz KD; Pourcher E; Docu-Axelerad A; Lew M; Kozyolkin O; Neale A; Resburg C; Meya U; Kenney C; Bandak S
Lancet Neurol; 2014 Aug; 13(8):767-76. PubMed ID: 25008546
[TBL] [Abstract][Full Text] [Related]
22. [Helicobacter pylori infection and its influence on Parkinson disease].
Włodarek D; Pakszys W; Bujko J
Pol Merkur Lekarski; 2003 Nov; 15(89):428-31. PubMed ID: 14969136
[TBL] [Abstract][Full Text] [Related]
23. Association between Helicobacter pylori infection and MALT-type lymphoma of the ocular adnexa: clinical and therapeutic implications.
Ferreri AJ; Ponzoni M; Viale E; Guidoboni M; Conciliis CD; Resti AG; Politi L; Lettini AA; Sacchetti F; Dognini G; Dolcetti R; Doglioni C
Hematol Oncol; 2006 Mar; 24(1):33-7. PubMed ID: 16385613
[TBL] [Abstract][Full Text] [Related]
24. Gastrointestinal dysfunction in Parkinson's disease.
Fasano A; Visanji NP; Liu LW; Lang AE; Pfeiffer RF
Lancet Neurol; 2015 Jun; 14(6):625-39. PubMed ID: 25987282
[TBL] [Abstract][Full Text] [Related]
25. An alternative medicine treatment for Parkinson's disease: results of a multicenter clinical trial. HP-200 in Parkinson's Disease Study Group.
J Altern Complement Med; 1995; 1(3):249-55. PubMed ID: 9395621
[TBL] [Abstract][Full Text] [Related]
26. [Helicobacter pylori infection in children: a new focus].
Yee KC
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Mar; 16(3):248-54. PubMed ID: 24661515
[TBL] [Abstract][Full Text] [Related]
27. [Role of Helicobacter pylori infection and use of NSAIDs in the etiopathogenesis of upper gastrointestinal bleeding].
Sokić-Milutinović A; Krstić M; Popović D; Mijalković N; Djuranović S; Culafić Dj
Acta Chir Iugosl; 2007; 54(1):51-62. PubMed ID: 17633863
[TBL] [Abstract][Full Text] [Related]
28. Entacapone: a catechol-O-methyltransferase inhibitor for the adjunctive treatment of Parkinson's disease.
Najib J
Clin Ther; 2001 Jun; 23(6):802-32; discussion 771. PubMed ID: 11440283
[TBL] [Abstract][Full Text] [Related]
29. H. pylori and Parkinson's disease: Meta-analyses including clinical severity.
Dardiotis E; Tsouris Z; Mentis AA; Siokas V; Michalopoulou A; Sokratous M; Dastamani M; Bogdanos DP; Deretzi G; Kountouras J
Clin Neurol Neurosurg; 2018 Dec; 175():16-24. PubMed ID: 30308319
[TBL] [Abstract][Full Text] [Related]
30. Helicobacter pylori, chronic gastritis and peptic ulcer.
Sipponen P
Mater Med Pol; 1992; 24(3):166-8. PubMed ID: 1307646
[TBL] [Abstract][Full Text] [Related]
31. Coherence of neuronal firing of the entopeduncular nucleus with motor cortex oscillatory activity in the 6-OHDA rat model of Parkinson's disease with levodopa-induced dyskinesias.
Jin X; Schwabe K; Krauss JK; Alam M
Exp Brain Res; 2016 Apr; 234(4):1105-18. PubMed ID: 26724931
[TBL] [Abstract][Full Text] [Related]
32. Dyskinesias and motor fluctuations in Parkinson's disease. A community-based study.
Schrag A; Quinn N
Brain; 2000 Nov; 123 ( Pt 11)():2297-305. PubMed ID: 11050029
[TBL] [Abstract][Full Text] [Related]
33. Current management of motor fluctuations in patients with advanced Parkinson's disease treated chronically with levodopa.
Melamed E; Zoldan J; Galili-Mosberg R; Ziv I; Djaldetti R
J Neural Transm Suppl; 1999; 56():173-83. PubMed ID: 10370911
[TBL] [Abstract][Full Text] [Related]
34. Nonsteroidal antiinflammatory drug-associated gastric ulcers do not require Helicobacter pylori for their development.
Laine L; Marin-Sorensen M; Weinstein WM
Am J Gastroenterol; 1992 Oct; 87(10):1398-402. PubMed ID: 1415094
[TBL] [Abstract][Full Text] [Related]
35. [What is new in treating Helicobacter pylori infection?].
Scherübl H; Fischbach W; Glocker E; Malfertheiner P
Dtsch Med Wochenschr; 2015 Feb; 140(4):277-80. PubMed ID: 25704525
[TBL] [Abstract][Full Text] [Related]
36. Various aspects of motor fluctuations and their management in Parkinson's disease.
Mizuno Y; Kondo T; Mori H
Neurology; 1994 Jul; 44(7 Suppl 6):S29-34. PubMed ID: 8047258
[TBL] [Abstract][Full Text] [Related]
37. Association of Helicobacter pylori with Parkinson's Disease.
Mridula KR; Borgohain R; Chandrasekhar Reddy V; Bandaru VCh; Suryaprabha T
J Clin Neurol; 2017 Apr; 13(2):181-186. PubMed ID: 28406585
[TBL] [Abstract][Full Text] [Related]
38. Force overflow and levodopa-induced dyskinesias in Parkinson's disease.
Wenzelburger R; Zhang BR; Pohle S; Klebe S; Lorenz D; Herzog J; Wilms H; Deuschl G; Krack P
Brain; 2002 Apr; 125(Pt 4):871-9. PubMed ID: 11912119
[TBL] [Abstract][Full Text] [Related]
39. Helicobacter pylori prevalence in a routine upper gastrointestinal endoscopy population.
Sandikci MU; Doran F; Koksal F; Sandikci S; Uluhan R; Varinli S; Akan E
Br J Clin Pract; 1993; 47(4):187-9. PubMed ID: 8260335
[TBL] [Abstract][Full Text] [Related]
40. [Parkinson's disease treatment: from honey moon to motor fluctuations].
Laurencin C; Danaila T; Thobois S
Rev Prat; 2018 May; 68(5):502-507. PubMed ID: 30869413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
